Trademarkia Logo

Canada

C$
LAVA THERAPEUTICS
REGISTERED

on 4 Oct 2023

Last Applicant/ Owned by

Lava Therapeutics N.V.

Yalelaan 60NL-3584 CM Utrecht

NL

Serial Number

2152686 filed on 7th Sept 2021

Registration Number

TMA1201843 registered on 4th Oct 2023

Registration expiry Date

7th Sept 2031

Correspondent Address

SMART & BIGGAR LP

Scotia Plaza, 40 King Street West40th FloorToronto

ONTARIO

CA

M5H3Y2

LAVA THERAPEUTICS

Trademark usage description

antibodies for scientific and research use; proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use i Read More

Vienna Information


6 . 1 . 3

VolcanoesVolcans

6 . 1 . 4

Mountains or volcanoes stylizedMontagnes ou volcans stylisés

26 . 4 . 3

Rhombs or squares standing on one of the corners thereofLosanges ou carrés sur pointe

26 . 4 . 5

One quadrilateralUn quadrilatère

26 . 4 . 16

Quadrilaterals containing other figurative elementsQuadrilatères contenant d'autres éléments figuratifs

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

26 . 4 . 12

Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

26 . 11 . 3

More than two lines or two bandsPlus de deux lignes ou de deux bandes

26 . 11 . 12

Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)

29 . 1 . 5

VioletViolet

29 . 1 . 2

Yellow, goldJaune, or

29 . 1 . 1

Red, pink, orangeRouge, rose, orangé

Classification Information


Class [001]
Antibodies for scientific and research use; proteins, enzymes, diagnostic reagents, and chemical and biochemical preparations and substances for use in the manufacture of medicines.


Classification kind code

11

Class [005]
Pharmaceutical preparations for T Cell therapy; pharmaceutical products for the prevention and treatment of cancer; immunotherapy products, namely, pharmaceutical preparations for the treatment of cancer, autoimmune diseases, and immunological disorders; biological preparations, namely biopharmaceuticals, for the treatment of cancer autoimmune diseases, and immunological disorders; biological preparations made from human blood cells for the treatment of cancer, autoimmune diseases, and immunological disorders; chemical and biochemical preparations, and pharmaceutical substances for medical purposes for the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders; antibodies and libraries of antibodies for medical purposes, for treatment and/or diagnosis of cancer, autoimmune diseases and immunological disorders.


Classification kind code

11

Class [042]
Bio-technology and scientific services, namely, research and development services relating to bio-technology and science in the field of antibodies, proteins and enzymes; pharmaceutical research and development; biological and bio-technology analysis services; scientific and medical laboratory services; biochemistry research services, namely, antibodies, protein and enzyme evolving services; biochemistry research services, namely, antibodies, protein and enzyme cataloging and antibodies, protein and enzyme library services; laboratory services relating to the production of antibodies, proteins and enzymes.


Classification kind code

11

Class [044]
Providing information about the treatment and diagnosis of cancer, autoimmune diseases and immunological disorders via a website.


Classification kind code

11

Mark Details


Serial Number

2152686

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 22nd Mar 2023
Search Recorded
Submitted for opposition 20
on 22nd Mar 2023
Examiner's First Report
Submitted for opposition 48
on 7th Feb 2023
Agent Changed
Submitted for opposition 256
on 10th Oct 2022
Notification of Possible Opposition Sent
Submitted for opposition 135
on 2th Mar 2022
Amendment to Application
Submitted for opposition 257
on 9th Dec 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 8th Dec 2021
Formalized
Submitted for opposition 1
on 8th Dec 2021
Created
Submitted for opposition 228
on 7th Sept 2021
International Registration
Submitted for opposition 30
on 7th Sept 2021
Filed